Strong pipeline of monoclonal antibodies (mAbs) biosimilars in the US and Europe
The market is expected to soar from $1.2 billion of 2013 to $24 billion in 2019
31-Jan-2014 -
The imminent entry of several companies, including big pharma, small biotech and generic participants, into the global biosimilars space will propel the market towards exponential growth. Already, Indian groups such as Dr. Reddy’s Laboratories, Biocon and Reliance Life Sciences are making a ...
biosimilars
Frost & Sullivan
molecular weight
+2